GRAIL, LLC (NASDAQ:GRAL) — Market Cap & Net Worth
Market Cap & Net Worth: GRAIL, LLC (GRAL)
GRAIL, LLC (NASDAQ:GRAL) has a market capitalization of $2.58 Billion ($2.58 Billion) as of June 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #5495 globally and #1757 in its home market, demonstrating a 8.79% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GRAIL, LLC's stock price $63.74 by its total outstanding shares 42916593 (42.92 Million). Review debt load of GRAIL, LLC to assess the company's total debt and financial obligations.
GRAIL, LLC Market Cap History: 2024 to 2026
GRAIL, LLC's market capitalization history from 2024 to 2026. Data shows growth from $766.06 Million to $2.74 Billion (77.39% CAGR).
Index Memberships
GRAIL, LLC is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.42 Trillion | 0.11% | #130 of 976 |
|
NASDAQ Composite
IXIC
|
$41.03 Trillion | 0.01% | #601 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.69 Trillion | 0.15% | #83 of 263 |
Weight: GRAIL, LLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GRAIL, LLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GRAIL, LLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
24.96x
GRAIL, LLC's market cap is 24.96 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $766.06 Million | $125.59 Million | -$2.03 Billion | 6.10x | N/A |
| 2025 | $3.67 Billion | $147.17 Million | -$408.35 Million | 24.96x | N/A |
Competitor Companies of GRAL by Market Capitalization
Companies near GRAIL, LLC in the global market cap rankings as of June 19, 2026.
Key companies related to GRAIL, LLC by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #131 globally with a market cap of $174.56 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $125.14 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #621 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #664 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #131 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.56 Billion | $464.61 |
| #189 | Danaher Corporation | NYSE:DHR | $125.14 Billion | $177.17 |
| #621 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $562.09 |
| #664 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
GRAIL, LLC Historical Marketcap From 2024 to 2026
Between 2024 and today, GRAIL, LLC's market cap moved from $766.06 Million to $ 2.74 Billion, with a yearly change of 77.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.74 Billion | -25.53% |
| 2025 | $3.67 Billion | +379.50% |
| 2024 | $766.06 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of GRAIL, LLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.58 Billion USD |
| MoneyControl | $2.58 Billion USD |
| MarketWatch | $2.58 Billion USD |
| marketcap.company | $2.58 Billion USD |
| Reuters | $2.58 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GRAIL, LLC
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides deve… Read more